Real World Data

The Real World Data (RWD) Initiative aims to collaborate with global regulatory agencies and other stakeholders to develop a framework for RWD that provides tools, methodologies, case studies, and appropriate levels of evidence to support regulatory decision-making.

Rationale

Supplementing or replacing clinical trial data with Real World Data (RWD) to inform regulatory decisions is a transformative, ambitious goal that has the potential to substantially contribute to the totality of evidence regarding the benefits and risks of drug products. Leveraging RWD can benefit patients, researchers, and regulators, among others.

Benefits

Enhanced evidence generation through RWD potentially leading to improved patient outcomes
Enhanced credibility and increased awareness of appropriate use of RWD
Increased confidence in acceptance of RWD for regulatory decision making

Available Solutions

Initiative Solutions

For more information and to explore our solutions, visit our Initiative Solutions page.

Related Initiatives

Historical Trial Data Sharing (Controls) Solutions

The Historical Trial Data Sharing Initiative enables the sharing of historical trial data to maximize the value of clinical data collected in the control arms of clinical trials. Explore the materials below to learn more about our findings. Please note, the Historical Trial Data Sharing Initiative was formerly known as “Placebo and Standard of Care.”…

eSource Solutions

What is eSource? The Food and Drug Administration (FDA) defines eSource, or electronic source data, as data initially recorded in an electronic format. The TransCelerate eSource workstream further categorizes eSource into the four groups shown below: *The eSource team recognizes that some technologies may apply to more than one modality and that these modalities will…

Digital Data Flow Solutions

TransCelerate’s Digital Data Flow (DDF) Initiative offers a mechanism to digitize clinical study components to enable interoperability and reuse, across the study lifecycle starting with study design. TransCelerate has collaborated with CDISC and other stakeholders to develop a standard data model for specifying protocol information, as well as a demonstrated way to connect disparate systems…